These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35593163)
1. Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020. Dabrera G; Allen H; Zaidi A; Flannagan J; Twohig K; Thelwall S; Marchant E; Aziz NA; Lamagni T; Myers R; Charlett A; Capelastegui F; Chudasama D; Clare T; Coukan F; Sinnathamby M; Ferguson N; Hopkins S; Chand M; Hope R; Kall M; Euro Surveill; 2022 May; 27(20):. PubMed ID: 35593163 [TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296 [TBL] [Abstract][Full Text] [Related]
4. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2. Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study. Krutikov M; Stirrup O; Nacer-Laidi H; Azmi B; Fuller C; Tut G; Palmer T; Shrotri M; Irwin-Singer A; Baynton V; Hayward A; Moss P; Copas A; Shallcross L; Lancet Healthy Longev; 2022 May; 3(5):e347-e355. PubMed ID: 35531432 [TBL] [Abstract][Full Text] [Related]
6. Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England. Forbes H; Morton CE; Bacon S; McDonald HI; Minassian C; Brown JP; Rentsch CT; Mathur R; Schultze A; DeVito NJ; MacKenna B; Hulme WJ; Croker R; Walker AJ; Williamson EJ; Bates C; Mehrkar A; Curtis HJ; Evans D; Wing K; Inglesby P; Drysdale H; Wong AYS; Cockburn J; McManus R; Parry J; Hester F; Harper S; Douglas IJ; Smeeth L; Evans SJW; Bhaskaran K; Eggo RM; Goldacre B; Tomlinson LA BMJ; 2021 Mar; 372():n628. PubMed ID: 33737413 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland. Kerr S; Vasileiou E; Robertson C; Sheikh A J Glob Health; 2022 Jul; 12():05025. PubMed ID: 35802764 [TBL] [Abstract][Full Text] [Related]
8. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey. Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041 [TBL] [Abstract][Full Text] [Related]
9. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH; BMJ; 2022 Mar; 376():e069761. PubMed ID: 35264324 [TBL] [Abstract][Full Text] [Related]
10. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study. Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG; Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231 [TBL] [Abstract][Full Text] [Related]
11. Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study. Hippisley-Cox J; Khunti K; Sheikh A; Nguyen-Van-Tam JS; Coupland CAC BMJ; 2023 Jun; 381():e072976. PubMed ID: 37343968 [TBL] [Abstract][Full Text] [Related]
12. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis. Nyberg T; Twohig KA; Harris RJ; Seaman SR; Flannagan J; Allen H; Charlett A; De Angelis D; Dabrera G; Presanis AM BMJ; 2021 Jun; 373():n1412. PubMed ID: 34130987 [TBL] [Abstract][Full Text] [Related]
13. Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England. Webster HH; Nyberg T; Sinnathamby MA; Aziz NA; Ferguson N; Seghezzo G; Blomquist PB; Bridgen J; Chand M; Groves N; Myers R; Hope R; Ashano E; Lopez-Bernal J; De Angelis D; Dabrera G; Presanis AM; Thelwall S Nat Commun; 2022 Oct; 13(1):6053. PubMed ID: 36229438 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study. Donati S; Corsi E; Maraschini A; Salvatore MA; BJOG; 2022 Jan; 129(2):221-231. PubMed ID: 34687585 [TBL] [Abstract][Full Text] [Related]
15. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study. Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279 [TBL] [Abstract][Full Text] [Related]
16. Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves. Dave N; Sjöholm D; Hedberg P; Ternhag A; Granath F; Verberk JDM; Johansson AF; van der Werff SD; Nauclér P JAMA Netw Open; 2023 Nov; 6(11):e2341936. PubMed ID: 37948082 [TBL] [Abstract][Full Text] [Related]
17. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Bager P; Wohlfahrt J; Bhatt S; Stegger M; Legarth R; Møller CH; Skov RL; Valentiner-Branth P; Voldstedlund M; Fischer TK; Simonsen L; Kirkby NS; Thomsen MK; Spiess K; Marving E; Larsen NB; Lillebaek T; Ullum H; Mølbak K; Krause TG; Lancet Infect Dis; 2022 Jul; 22(7):967-976. PubMed ID: 35468331 [TBL] [Abstract][Full Text] [Related]
18. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Mathur R; Rentsch CT; Morton CE; Hulme WJ; Schultze A; MacKenna B; Eggo RM; Bhaskaran K; Wong AYS; Williamson EJ; Forbes H; Wing K; McDonald HI; Bates C; Bacon S; Walker AJ; Evans D; Inglesby P; Mehrkar A; Curtis HJ; DeVito NJ; Croker R; Drysdale H; Cockburn J; Parry J; Hester F; Harper S; Douglas IJ; Tomlinson L; Evans SJW; Grieve R; Harrison D; Rowan K; Khunti K; Chaturvedi N; Smeeth L; Goldacre B; Lancet; 2021 May; 397(10286):1711-1724. PubMed ID: 33939953 [TBL] [Abstract][Full Text] [Related]
19. Wastewater monitoring for detection of public health markers during the COVID-19 pandemic: Near-source monitoring of schools in England over an academic year. Hassard F; Vu M; Rahimzadeh S; Castro-Gutierrez V; Stanton I; Burczynska B; Wildeboer D; Baio G; Brown MR; Garelick H; Hofman J; Kasprzyk-Hordern B; Majeed A; Priest S; Denise H; Khalifa M; Bassano I; Wade MJ; Grimsley J; Lundy L; Singer AC; Di Cesare M PLoS One; 2023; 18(5):e0286259. PubMed ID: 37252922 [TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]